These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22474621)

  • 1. Bone fragility in type 2 diabetes mellitus.
    Yamaguchi T
    World J Orthop; 2010 Nov; 1(1):3-9. PubMed ID: 22474621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone metabolism and fracture risk in type 2 diabetes mellitus.
    Yamaguchi T; Sugimoto T
    Bonekey Rep; 2012; 1():36. PubMed ID: 23951442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone metabolism and fracture risk in type 2 diabetes mellitus [Review].
    Yamaguchi T; Sugimoto T
    Endocr J; 2011; 58(8):613-24. PubMed ID: 21778617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus.
    Raška I; Rašková M; Zikán V; Škrha J
    Cent Eur J Public Health; 2017 Mar; 25(1):3-10. PubMed ID: 28399348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes mellitus and osteoporosis. Predictive candidate markers for fracture risk in diabetic patients].
    Yamamoto M
    Clin Calcium; 2012 Sep; 22(9):1359-65. PubMed ID: 22932290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis, fractures, and diabetes.
    Jackuliak P; Payer J
    Int J Endocrinol; 2014; 2014():820615. PubMed ID: 25050121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Bone Mineral Density, Bone Turnover Markers, and Vertebral Fractures with All-Cause Mortality in Type 2 Diabetes Mellitus.
    Miyake H; Kanazawa I; Sugimoto T
    Calcif Tissue Int; 2018 Jan; 102(1):1-13. PubMed ID: 28965188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fracture Risk Assessment in Patients With Diabetes Mellitus.
    Poiana C; Capatina C
    J Clin Densitom; 2017; 20(3):432-443. PubMed ID: 28716499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of bone fragility by pulsed electromagnetic fields in type 2 diabetic KK-Ay mice involving Wnt/β-catenin signaling.
    Shao X; Yang Y; Tan Z; Ding Y; Luo E; Jing D; Cai J
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E951-E966. PubMed ID: 33719588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary Pentosidine levels negatively associates with trabecular bone scores in patients with type 2 diabetes mellitus.
    Choi YJ; Ock SY; Jin Y; Lee JS; Kim SH; Chung Y-
    Osteoporos Int; 2018 Apr; 29(4):907-915. PubMed ID: 29322222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.
    Kanazawa I; Notsu M; Miyake H; Tanaka K; Sugimoto T
    Osteoporos Int; 2018 Nov; 29(11):2527-2535. PubMed ID: 30030585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, Type 2 Diabetes and Bone in Adults.
    Walsh JS; Vilaca T
    Calcif Tissue Int; 2017 May; 100(5):528-535. PubMed ID: 28280846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of diabetes and its treatments on skeletal diseases.
    Yan W; Li X
    Front Med; 2013 Mar; 7(1):81-90. PubMed ID: 23377889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalent vertebral fracture is dominantly associated with spinal microstructural deterioration rather than bone mineral density in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    PLoS One; 2019; 14(9):e0222571. PubMed ID: 31525243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review.
    Anagnostis P; Paschou SA; Gkekas NN; Artzouchaltzi AM; Christou K; Stogiannou D; Vryonidou A; Potoupnis M; Goulis DG
    Endocrine; 2018 Jun; 60(3):373-383. PubMed ID: 29411304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of diabetes mellitus-induced bone fragility.
    Napoli N; Chandran M; Pierroz DD; Abrahamsen B; Schwartz AV; Ferrari SL;
    Nat Rev Endocrinol; 2017 Apr; 13(4):208-219. PubMed ID: 27658727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone disorders associated with diabetes mellitus and its treatments.
    Cortet B; Lucas S; Legroux-Gerot I; Penel G; Chauveau C; Paccou J
    Joint Bone Spine; 2019 May; 86(3):315-320. PubMed ID: 30098423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative ultrasound and vertebral fractures in patients with type 2 diabetes.
    Yamaguchi T; Yamamoto M; Kanazawa I; Yamauchi M; Yano S; Tanaka N; Nitta E; Fukuma A; Uno S; Sho-no T; Sugimoto T
    J Bone Miner Metab; 2011 Sep; 29(5):626-32. PubMed ID: 21437613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of bone strength and factors associated with vertebral fracture in postmenopausal women with type 2 diabetes.
    Chen FP; Kuo SF; Lin YC; Fan CM; Chen JF
    Menopause; 2019 Feb; 26(2):182-188. PubMed ID: 30130285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.